Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Does ambulatory oxygen improve quality of life in patients with fibrotic lung disease? Results from the AmbOx trial.

Creamer AW, Barratt SL.

Breathe (Sheff). 2019 Jun;15(2):140-143. doi: 10.1183/20734735.0002-2019.

2.

Musical instruments, fungal spores and hypersensitivity pneumonitis.

Davidson J, McErlane J, Aljboor K, Barratt SL, Jeyabalan A, Medford ARL, Borman AM, Adamali H.

QJM. 2019 Apr 1;112(4):287-289. doi: 10.1093/qjmed/hcz020. No abstract available.

PMID:
30649525
3.

Specialist palliative care, psychology, interstitial lung disease (ILD) multidisciplinary team meeting: a novel model to address palliative care needs.

Barratt SL, Morales M, Spiers T, Al Jboor K, Lamb H, Mulholland S, Edwards A, Gunary R, Meek P, Jordan N, Sharp C, Kendall C, Adamali HI.

BMJ Open Respir Res. 2018 Dec 19;5(1):e000360. doi: 10.1136/bmjresp-2018-000360. eCollection 2018.

4.

South-West of England's Experience of the Safety and Tolerability Pirfenidone and Nintedanib for the Treatment of Idiopathic Pulmonary Fibrosis (IPF).

Barratt SL, Mulholland S, Al Jbour K, Steer H, Gutsche M, Foley N, Srivastava R, Sharp C, Adamali HI.

Front Pharmacol. 2018 Dec 17;9:1480. doi: 10.3389/fphar.2018.01480. eCollection 2018.

5.

Pancytopaenia and breathlessness: Hickam's Dictum prevails!

Creamer AW, Protheroe R, Gunawardena H, Barratt SL.

Thorax. 2018 Dec;73(12):1187-1190. doi: 10.1136/thoraxjnl-2018-212088. Epub 2018 Aug 18. No abstract available.

PMID:
30121573
6.

The Role of Vascular Endothelial Growth Factor in Systemic Sclerosis.

Flower VA, Barratt SL, Ward S, Pauling JD.

Curr Rheumatol Rev. 2019;15(2):99-109. doi: 10.2174/1573397114666180809121005.

PMID:
30091416
7.

Idiopathic Pulmonary Fibrosis (IPF): An Overview.

Barratt SL, Creamer A, Hayton C, Chaudhuri N.

J Clin Med. 2018 Aug 6;7(8). pii: E201. doi: 10.3390/jcm7080201. Review.

8.

Pleuroparenchymal sarcoidosis - A recognised but rare manifestation of disease.

Walker S, Adamali H, Bhatt N, Maskell N, Barratt SL.

Respir Med Case Rep. 2018 Feb 3;23:110-114. doi: 10.1016/j.rmcr.2018.01.007. eCollection 2018.

9.

VEGF (Vascular Endothelial Growth Factor) and Fibrotic Lung Disease.

Barratt SL, Flower VA, Pauling JD, Millar AB.

Int J Mol Sci. 2018 Apr 24;19(5). pii: E1269. doi: 10.3390/ijms19051269. Review.

10.

Physiological predictors of Hypoxic Challenge Testing (HCT) outcomes in Interstitial Lung Disease (ILD).

Barratt SL, Shaw J, Jones R, Bibby A, Adamali H, Mustfa N, Cliff I, Stone H, Chaudhuri N.

Respir Med. 2018 Feb;135:51-56. doi: 10.1016/j.rmed.2017.12.015. Epub 2018 Jan 8.

PMID:
29414453
11.

Effects of hypoxia and hyperoxia on the differential expression of VEGF-A isoforms and receptors in Idiopathic Pulmonary Fibrosis (IPF).

Barratt SL, Blythe T, Ourradi K, Jarrett C, Welsh GI, Bates DO, Millar AB.

Respir Res. 2018 Jan 15;19(1):9. doi: 10.1186/s12931-017-0711-x.

12.

Conservative Management in Traumatic Pneumothoraces: An Observational Study.

Walker SP, Barratt SL, Thompson J, Maskell NA.

Chest. 2018 Apr;153(4):946-953. doi: 10.1016/j.chest.2017.10.015. Epub 2017 Nov 15.

PMID:
29080710
13.

Differential Expression of VEGF-Axxx Isoforms Is Critical for Development of Pulmonary Fibrosis.

Barratt SL, Blythe T, Jarrett C, Ourradi K, Shelley-Fraser G, Day MJ, Qiu Y, Harper S, Maher TM, Oltean S, Hames TJ, Scotton CJ, Welsh GI, Bates DO, Millar AB.

Am J Respir Crit Care Med. 2017 Aug 15;196(4):479-493. doi: 10.1164/rccm.201603-0568OC.

14.

VEGF isoforms have differential effects on permeability of human pulmonary microvascular endothelial cells.

Ourradi K, Blythe T, Jarrett C, Barratt SL, Welsh GI, Millar AB.

Respir Res. 2017 Jun 2;18(1):116. doi: 10.1186/s12931-017-0602-1.

15.

An evaluation of blood creatinine measurement by creatinase on the NOVA M7 blood gas analyzer.

Rowe DJ, Omar H, Barratt SL, Biggs P.

Clin Chim Acta. 2001 May;307(1-2):23-5.

PMID:
11369332

Supplemental Content

Loading ...
Support Center